NIK modulators (Celgene)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameNIK modulators (Celgene)
Drug Alias NameNIK modulators (Signal)NIK modulators (Serono)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitogen-Activated Protein Kinase Kinase Kinase 14 modulators
TargetsMitogen-Activated Protein Kinase Kinase Kinase 14
Therapy Area/IndicationsAtherosclerosisAsthmaOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSignal Research Division
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Serono SaSignal Research Division
Active IndicationsN/A
Inactive IndicationsAtherosclerosisAsthmaOvarian Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A